Tetradecanehydrazide

Tetradecanehydrazide

SCHEMBL945985

CCCCCCCCCCCCCC(=O)NN

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSD P07339 1/20 0.65
HSP90AA1 P07900 1/20 0.64
FAAH O00519 4/20 0.61
MEN1 O00255 2/20 0.57
KMT2A Q03164 2/20 0.57
MAPK1 P28482 1/20 0.57
ALDH1A1 P00352 3/20 0.55
DNM1 Q05193 1/20 0.55
CES2 O00748 3/20 0.54
CES1 P23141 3/20 0.54
PPARG P37231 6/20 0.52
PPARD Q03181 6/20 0.52
PPARA Q07869 6/20 0.52
GPR84 Q9NQS5 5/20 0.52
HDAC11 Q96DB2 5/20 0.52
TSHR P16473 4/20 0.52
TLR2 O60603 2/20 0.52
TDP1 Q9NUW8 2/20 0.52
FABP4 P15090 2/20 0.52
PTPN1 P18031 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5519669 1.00 CTSD (0.65) CTSDHSP90AA1FAAHMEN1KMT2A
SCHEMBL998990 1.00 CTSD (0.65) CTSDHSP90AA1FAAHMEN1KMT2A
SCHEMBL945586 1.00 CTSD (0.65) CTSDHSP90AA1FAAHMEN1KMT2A
SCHEMBL2920943 1.00 CTSD (0.65) CTSDHSP90AA1FAAHMEN1KMT2A
SCHEMBL3110219 1.00 CTSD (0.65) CTSDHSP90AA1FAAHMEN1KMT2A
SCHEMBL1272524 1.00 CTSD (0.65) CTSDHSP90AA1FAAHMEN1KMT2A
SCHEMBL944700 1.00 CTSD (0.65) CTSDHSP90AA1FAAHMEN1KMT2A
SCHEMBL765863 1.00 CTSD (0.65) CTSDHSP90AA1FAAHMEN1KMT2A
SCHEMBL946992 1.00 CTSD (0.65) CTSDHSP90AA1FAAHMEN1KMT2A
SCHEMBL765585 1.00 CTSD (0.65) CTSDHSP90AA1FAAHMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115702902-B Anti-tumor preparation of doxorubicin prodrug 苏州裕泰医药科技有限公司 2024-04-26 CN claimed
CN-116925159-A Maltose acylhydrazone emulsifier and preparation method thereof 江苏大学 2023-10-24 CN claimed
CN-107827773-A A kind of preparation method of tridecyl amine 三门峡奥科化工有限公司 2018-03-23 CN claimed
US-5527385-A CONTAINING ELECTRON DONATING CHROMOGENIC COMPOUND, ELECTRON ACCEPTING COMPOUND, HYDRAZIDE COMPOUND DESENSITIZER, TRANSITION TEMPERATURE MODIFIER SAKURA COLOR PRODUCTS CORPORATION (JP) 1996-06-18 US claimed
EP-3910014-B1 POLYACETAL RESIN COMPOSITION ASAHI CHEMICAL IND (JP) 2025-06-25 EP disclosed
US-12338408-B2 Lubricating oil composition ENEOS CORPORATION (JP) 2025-06-24 US disclosed
CN-119424667-A Cholesterol derivative pharmaceutical composition and preparation method and application thereof 沈阳药科大学 2025-02-14 CN disclosed
EP-3878929-B1 LUBRICANT COMPOSITION ENEOS CORP (JP) 2025-01-01 EP disclosed
EP-3878930-B1 LUBRICATING OIL COMPOSITION ENEOS CORP (JP) 2024-07-31 EP disclosed
EP-3594282-B1 RUBBER COMPOSITION AND TIRE OTSUKA CHEMICAL CO LTD (JP) 2024-07-17 EP disclosed
EP-3878928-B1 LUBRICANT COMPOSITION ENEOS CORP (JP) 2024-05-22 EP disclosed
WO-2023210218-A1 LUBRICATING OIL COMPOSITION ENEOS株式会社 2023-11-02 WO disclosed
US-20060141019-A1 Liposome NIPRO CORPORATION (JP) 2006-06-29 US disclosed
EP-1579850-A2 A pharmaceutical composition containing liposomes for treating a cancer Nipro Corporation (JP) 2005-09-28 EP disclosed
EP-1568360-A1 LIPOSOME Nipro Corporation (JP) 2005-08-31 EP disclosed
US-20050158375-A1 Pharmaceutical composition containing liposomes for treating cancer NIPRO CORPORATION (JP) 2005-07-21 US disclosed
WO-1999014204-A1 SUBSTITUTED 1,2,4-TRIAZOLES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY G.D. SEARLE & CO. (US) 1999-03-25 WO disclosed
US-5527385-A CONTAINING ELECTRON DONATING CHROMOGENIC COMPOUND, ELECTRON ACCEPTING COMPOUND, HYDRAZIDE COMPOUND DESENSITIZER, TRANSITION TEMPERATURE MODIFIER SAKURA COLOR PRODUCTS CORPORATION (JP) 1996-06-18 US disclosed
US-5185358-A Anticholesterol agents WARNER-LAMBERT CO. (US) 1993-02-09 US disclosed
US-4035484-A DISINFECTING, SWIMMING POOL WATER OLIN CORPORATION (US) 1977-07-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060141019-A1 Liposome LIPA, CLPTM1L, LPCAT1 CTSD 2623/4885HSP90AA1 1583/4885FAAH 512/4885
US-20050158375-A1 Pharmaceutical composition containing liposomes for treating cancer LIPA, PHOSPHO1, CETP CTSD 1783/4885HSP90AA1 1630/4885FAAH 960/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.